NDC 0409-6695

Amidate

Etomidate

Amidate is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Etomidate.

Product ID0409-6695_41253af6-deac-43de-9af3-3b727ea351d8
NDC0409-6695
Product TypeHuman Prescription Drug
Proprietary NameAmidate
Generic NameEtomidate
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2005-07-26
Marketing CategoryNDA / NDA
Application NumberNDA018227
Labeler NameHospira, Inc.
Substance NameETOMIDATE
Active Ingredient Strength2 mg/mL
Pharm ClassesGeneral Anesthesia [PE],General Anesthetic [EPC]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 0409-6695-01

10 VIAL, SINGLE-DOSE in 1 TRAY (0409-6695-01) > 10 mL in 1 VIAL, SINGLE-DOSE (0409-6695-11)
Marketing Start Date2005-07-26
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0409-6695-12 [00409669512]

Amidate INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018227
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2017-08-04

NDC 0409-6695-10 [00409669510]

Amidate INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018227
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2016-02-10
Marketing End Date2018-08-01

NDC 0409-6695-09 [00409669509]

Amidate INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018227
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2016-01-28
Marketing End Date2018-08-01

NDC 0409-6695-11 [00409669511]

Amidate INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018227
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2017-08-04

NDC 0409-6695-01 [00409669501]

Amidate INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018227
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2005-07-26

NDC 0409-6695-02 [00409669502]

Amidate INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018227
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2005-09-08

NDC 0409-6695-20 [00409669520]

Amidate INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018227
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2016-01-28
Marketing End Date2018-02-01

NDC 0409-6695-19 [00409669519]

Amidate INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018227
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2016-01-28
Marketing End Date2018-08-01

Drug Details

Active Ingredients

IngredientStrength
ETOMIDATE2 mg/mL

OpenFDA Data

SPL SET ID:b7ed5bf8-ba75-44dc-8f81-96b4ad5766be
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1654009
  • 1654008
  • 1654006
  • 1654011
  • 727531
  • 727533
  • Pharmacological Class

    • General Anesthesia [PE]
    • General Anesthetic [EPC]

    NDC Crossover Matching brand name "Amidate" or generic name "Etomidate"

    NDCBrand NameGeneric Name
    0404-9811AmidateEtomidate
    0409-6695AmidateETOMIDATE
    0409-8060AmidateEtomidate
    52584-695AmidateEtomidate
    0143-9310EtomidateEtomidate
    0143-9311EtomidateEtomidate
    0143-9506EtomidateEtomidate
    0143-9507EtomidateEtomidate
    23155-160EtomidateEtomidate
    23155-522EtomidateEtomidate
    25021-674etomidateetomidate
    51662-1485ETOMIDATEETOMIDATE
    51662-1542ETOMIDATEETOMIDATE
    55150-221ETOMIDATEETOMIDATE
    55150-222ETOMIDATEETOMIDATE
    65145-127EtomidateEtomidate
    65145-128EtomidateEtomidate
    65219-445EtomidateEtomidate
    65219-447EtomidateEtomidate
    65841-818etomidateetomidate
    67457-902EtomidateEtomidate
    67457-903EtomidateEtomidate
    68382-545etomidateetomidate
    70518-1003Etomidateetomidate

    Trademark Results [Amidate]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    AMIDATE
    AMIDATE
    77668975 3663648 Live/Registered
    Hospira, Inc.
    2009-02-12
    AMIDATE
    AMIDATE
    73119674 1078739 Dead/Expired
    ABBOTT LABORATORIES
    1977-03-21

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.